[go: up one dir, main page]

AU2036297A - Topical formulations of aciclovir - Google Patents

Topical formulations of aciclovir

Info

Publication number
AU2036297A
AU2036297A AU20362/97A AU2036297A AU2036297A AU 2036297 A AU2036297 A AU 2036297A AU 20362/97 A AU20362/97 A AU 20362/97A AU 2036297 A AU2036297 A AU 2036297A AU 2036297 A AU2036297 A AU 2036297A
Authority
AU
Australia
Prior art keywords
aciclovir
topical formulations
topical
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20362/97A
Inventor
John Ludwig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605859.9A external-priority patent/GB9605859D0/en
Priority claimed from GBGB9618975.8A external-priority patent/GB9618975D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2036297A publication Critical patent/AU2036297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU20362/97A 1996-03-20 1997-03-20 Topical formulations of aciclovir Abandoned AU2036297A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9605859.9A GB9605859D0 (en) 1996-03-20 1996-03-20 Medicaments
GB9605859 1996-03-20
GBGB9618975.8A GB9618975D0 (en) 1996-09-11 1996-09-11 Medicaments
GB9618975 1996-09-11
PCT/GB1997/000779 WO1997034607A1 (en) 1996-03-20 1997-03-20 Topical formulations of aciclovir

Publications (1)

Publication Number Publication Date
AU2036297A true AU2036297A (en) 1997-10-10

Family

ID=26308961

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20362/97A Abandoned AU2036297A (en) 1996-03-20 1997-03-20 Topical formulations of aciclovir

Country Status (2)

Country Link
AU (1) AU2036297A (en)
WO (1) WO1997034607A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618974D0 (en) * 1996-09-11 1996-10-23 Glaxo Group Ltd Medicaments
GB9718791D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Medicaments
ITMI981528A1 (en) * 1998-07-03 2000-01-03 Recordati Ind Chimica E Farma TOPICAL FORMULATIONS OF ACICLOVIR
AU2004202929B2 (en) * 1999-09-22 2006-11-23 B. Ron Johnson Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores
AU8206401A (en) 2000-08-03 2002-02-18 Antares Pharma Ipl Ag Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
FR2837102B1 (en) * 2002-03-18 2004-10-08 Palbian Snc AQUEOUS GEL COMPOSITION, MANUFACTURING METHOD AND USE FOR THE MANUFACTURE OF A MEDICAMENT, ESPECIALLY ANTIHERPETIC
EP1670433B1 (en) 2003-10-10 2011-11-23 Antares Pharma IPL AG Transdermal pharmaceutical formulation for minimizing skin residues
US7425340B2 (en) 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
CN101426475A (en) 2006-04-21 2009-05-06 安塔雷斯制药Ipl股份公司 Methods of treating hot flashes with formulations for transdermal or transmucosal application
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
GB201819418D0 (en) 2018-11-29 2019-01-16 Daniel Calladine Ltd Anti-viral compositions
CN115025119A (en) * 2022-06-15 2022-09-09 任嘉斌 Ointment for treating herpes zoster and herpes and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
US4973468A (en) * 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
JP3040427B2 (en) * 1989-05-18 2000-05-15 帝國製薬株式会社 Aspirin-containing ointment composition for treating neuralgia
IL104283A (en) * 1992-12-30 1996-12-05 Agis Ind 1983 Ltd Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate
US5540934A (en) * 1994-06-22 1996-07-30 Touitou; Elka Compositions for applying active substances to or through the skin

Also Published As

Publication number Publication date
WO1997034607A1 (en) 1997-09-25

Similar Documents

Publication Publication Date Title
AU6396896A (en) Stable topical compositions
AU9182498A (en) Taste masked formulations
AU7572196A (en) Pharmaceutical formulations
AU1850295A (en) Adhesive free topical pharmaceutical formulations
AU7177798A (en) Cosmetic preparations
AU2186797A (en) Pharmaceutically useful compounds
AU2655097A (en) Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
AU2036297A (en) Topical formulations of aciclovir
AU7177698A (en) Cosmetic preparations
AUPM740594A0 (en) Anti-inflammatory preparation
AU4905499A (en) Topical aciclovir formulations
AU7265596A (en) Probiotically acting formulations
AU5096298A (en) Gliadin-containing cosmetic formulations
AU4377397A (en) Novel therapeutically active adenosine derivatives
AU3460897A (en) Medicinal compositions
AU2953497A (en) Topical composition
AU1658997A (en) Topical composition
AU1933297A (en) Manufacture of elongate members
AUPN727595A0 (en) Therapeutic compositions
AU2969897A (en) Topical pharmaceutical formulations comprising aciclovir
AU8102498A (en) Preparation of diaryl-benzopyrans
AU2595297A (en) Use of aminoalkylcarboxylic derivatives
AU2350797A (en) Cosmetic preparation
AU7682796A (en) Topical phospholipid-containing acyclovir preparation
AU2975997A (en) Substituted amidinobenzene derivatives and medicinal compositions thereof